The transcription factor p63, member of the p53 family, is crucial for epithelial development. An RNAi screening identified the apoptotic gene Procaspase-8 as a target activated by p63. The caspase-8 inhibitor FLIP is also under p63 control. We analysed and detailed the direct transactivation through the use of RNAi, reporter assays, ChIPs, western blots, confocal studies in HaCat, as well as in primary human keratinocytes. The direct DNp63 regulation of these targets was confirmed in vivo using transgenic DNp63 mice under the K5 promoter, as compared with p63 knockout mice, and in vitro in normal human primary keratinocytes following UV irradiation. Lowering the steady state of p63 protein levels changes the relative ratio of FLIP isoforms, causing the activation of the expressed, inactive Procaspase-8, into the active isoform thus triggering the proapoptotic cascade. Therefore, p63 fine-tunes the Procaspase-8-FLIP pro-and antiapoptotic pathway in keratinocytes.
The transcription factor p63, member of the p53 family, is crucial for epithelial development. An RNAi screening identified the apoptotic gene Procaspase-8 as a target activated by p63. The caspase-8 inhibitor FLIP is also under p63 control. We analysed and detailed the direct transactivation through the use of RNAi, reporter assays, ChIPs, western blots, confocal studies in HaCat, as well as in primary human keratinocytes. The direct DNp63 regulation of these targets was confirmed in vivo using transgenic DNp63 mice under the K5 promoter, as compared with p63 knockout mice, and in vitro in normal human primary keratinocytes following UV irradiation. Lowering the steady state of p63 protein levels changes the relative ratio of FLIP isoforms, causing the activation of the expressed, inactive Procaspase-8, into the active isoform thus triggering the proapoptotic cascade. Therefore, p63 fine-tunes the Procaspase-8-FLIP pro-and antiapoptotic pathway in keratinocytes. p63 is a transcription factor homologous to p53 and p73.
1 p53 is a crucial transcription factor in response to DNA damage by impinging on cell-cycle control and proapoptotic pathways, 2 whereas p63 is involved in epithelial development. Six p63 proteins have been described, resulting from two distinct promoters (TAp63 and DNp63 isoforms) and from alternative mRNA splicing (isoforms a, b, g). TAp63 contain a transcriptional activation (TA) domain that is missing in the N-terminally deleted isoforms (DNp63); differential splicing generates isoforms with or without a sterile a motif domain, allegedly implicated in the protein-protein interactions. The relative properties and function of these isoforms are still not fully evident, but the major isoform present in keratinocytes and multilayered epithelia DNp63a is essential for ectodermal development in zebrafish, as well as in mammals. 3, 4 Indeed, the importance of p63 in skin development is shown by mice lacking p63 that die soon after birth with severe defects in limb, craniofacial and skin development. 4 In humans, several syndromes showing abnormalities in limbs, skin and epithelial annexes are caused by mutations in the p63 gene. 5 p63 is crucial for the activation of the epithelial cell adhesion programme. 6 Recently, p63 has been demonstrated to play a major role in maintaining the proliferative potential of stem cells of the multilayered epithelia. 1, 7 As for p53, the role of p63 in apoptosis has been investigated extensively. Although several reports have assigned a proapoptotic role to TAp63, DNp63a might exert a dominant-negative effect on the TAp63 isoforms, resulting in an antiapoptotic effect. [8] [9] [10] The identification of p63 target genes is key to our understanding of its biological role. Through the use of RNAi inactivation coupled to gene expression profiling and ChIP on chip, several labs have recently identified hundreds of p63 targets. 6, [11] [12] [13] [14] Specifically, procaspase-8 emerged in the RNAi profiling of human HaCat cells as a gene regulated by p63. 14 Caspases are an evolutionarily conserved family of aspartate-specific cystein-dependent proteases involved in apoptosis, as well as in inflammation. 15 Caspase-8 and -10 possess large prodomains containing related homotypic oligomerization motifs, such as the death effector domain (DED). Apoptotic stimuli triggers formation of the (deathinducing signalling complex) DISC, 16, 17 in which the procaspase-8, the inactive uncleaved form, is bound to the adaptor molecule FADD by two DED. 18 This association is necessary for processing of procaspase-8 into the active p10-p18 forms by proteolytic cleavage. These are released to the cytosol and mediate the activation of 'effectors' Caspases-3 and -7, which are predominantly responsible for the limited proteolysis characterizing the apoptotic destruction of the cell. The major control of procaspase 8 cleavage is exerted by c-FLIP, a molecule sharing homology to caspase-8, but lacking a functional protease domain. At the protein level, c-FLIP has three different isoforms -FLIPl, FLIPr and FLIPs -in humans, and two -FLIPl and FLIPr -in mice. [19] [20] [21] [22] [23] [24] In this report, we demonstrate that p63 activates the genes of both procaspase-8 and of its negative regulator, c-FLIP.
Results
The Caspase-8 gene is directly regulated by p63 in keratinocytes. By performing Affimetrix microarray analysis in HaCat cells silenced for p63 by siRNA, we identified genes regulated, directly or indirectly, by p63.
14 As caspase-8 emerged as a gene activated by p63, we validated it as a target by RT-PCR in HaCat and primary normal human epidermal keratinocytes -NHEK -following p63 RNAi: a concomitant decrease of p63 and caspase-8 was seen. Another p63 target -BI-1 -was also dramatically reduced, 13 compared with the housekeeping genes GAPDH and b-actin (Figure 1a) . Western Blot analysis confirmed the substantial decrease of DNp63a at the protein level (Figure 1a , bottom panels). As DNp63a is the most expressed p63 isoform in NHEK, we overexpressed this isoform in NHEK and analysed endogenous mRNA levels by semiquantitative RT-PCR (Figure 1b ): caspase-8 is indeed induced, whereas caspase-3 and caspase-9 are not. We conclude that caspase-8 is regulated by p63. To assess whether it is a direct target, we performed ChIP assays using anti-p63 and control antibodies on the promoter region. We selected amplicons in the core promoter area where conservation between human and mouse was stronger: strong positivity with the anti-p63 antibody in both HaCat and NHEK chromatin was observed ( Figure 1c) . As a control, we checked a region of the human BCoR gene, 25 which was not regulated by p63 and was devoid of any p63 binding ( Figure 1c, lower panel) .
Finally, we tested the transcriptional activity of the p63 isoforms in transient transfection assays with a caspase-8 promoter (À1 Kb to þ 100) fused to a CAT reporter in NHEK cells. As shown in Figure 1d , all p63 isoforms are able to transactivate the promoter, with different levels of efficiency: maximal for the TAp63 and minimal for the DNp63 isoforms. Altogether, these data indicate that caspase-8 is under direct regulation of p63 in human keratinocytes.
Caspase 8 expression in skin. We analysed the expression of caspase-8 in the skin of 19.5-day-old mouse embryos, using an antibody recognizing the procaspase form. Caspase-8 is expressed in the cytoplasm of all epidermal layers and staining is more intense in the basal and spinous layers, where p63 is also expressed (Figure 2 , upper panel). p63 null mice have only rare, scattered skin patches, identified by staining with anti-K14, a marker of the basal epidermis (Figure 2 , middle panels). In these areas, we detected very low expression of caspase-8 ( Figure 2 , middle panel), not proportional to the relative levels of K14 and far less than in normal animals. Finally, we analysed transgenic mice expressing DNp63a under the control of the Keratin 5 promoter, genetically complemented into p63-null background; these mice possess larger areas of epithelialization and re-express several differentiation markers. 26 As shown in Figure 2 (lower panels), these mice display strong caspase-8 expression in p63-positive cells, correctly localized in the cytoplasm, indicating that DNp63 positively influences caspase-8 expression in a genetically clean mouse model. Taken together, these data suggest that p63 is a major regulator of procaspase-8 expression.
p63 and caspase-8 in response to UV irradiation. As caspase-8 is involved in apoptosis, including UV irradiation, we examined its activity after exposure to increasing doses of UVB and UVC in NHEK. We performed immunofluorescence on irradiated NHEK, using an antibody specific for the cleaved, active form of caspase-8, caspase-3 and caspase-9. Caspase-8 is not activated 12 h after exposure to 50, 100 and 200 J/m 2 of UVC, unlike caspase-9 and -3 (Supplementary Figure 1) . After 12 h exposure to 250 and 400 J/m 2 of UVB light, NHEK display activated caspase-8 and -3, but not caspase-9, suggesting that the intrinsic pathway is active after UVC, whereas caspase-8 activation is observed only after UVB irradiation.
The levels of p63 were shown to decrease upon UVB irradiation in keratinocytes. 27, 28 We investigated whether p63 levels might impact on caspase-8 activation, functionally inactivating p63 in NHEK cells by shRNA: (Figure 3b , and data not shown). Reduction of p63 significantly increased caspase-8 activation, compared with the levels in control cells, as shown in confocal microscopy of irradiated keratinocytes with antibodies against cleaved caspase-8 (Figure 3a and c) . Cleaved caspase-8 is cytoplasmic and correlates to the highest level of p63 downregulation (Figure 3a , red arrow in the merge panel). In cells in which p63 downregulation is less efficient, cleaved caspase-8 staining is very weak (white arrow). Taken together, these results suggest that p63 elimination sensitizes NHEK to UVB-induced caspase-8 activation.
Next, we performed the reverse experiment, namely we assayed caspase-8 activation in UVB-irradiated NHEK after DNp63a overexpression. p63 levels were first checked by RT-PCR and western blots (Supplementary Figure 2) , and no effect was observed on caspase-8 activation in normal . We further confirmed this result by using a quantitative colorimetric assay for caspase-8 activation (Figure 4c ). These findings suggest a role for p63 not only in caspase-8 expression, but also in caspase-8 activation. Thus, we conclude that DNp63a protects against exposure to UVB irradiation, and that this counter correlates with caspase-8 activation.
Activation of caspase-8 in p63 KO. To assess whether caspase-8 is activated in epithelial cells of p63 KO and transgenic mice, we stained embryo skin sections from these mice with the cleaved caspase-8 antibody: as shown in Figure 5a , cleaved caspase-8 is not detectable in wt mice (upper panels), but is present in the Keratin 14 þ epithelial cells of p63 KO and DNp63a-tg mice (middle and lower panels). Compared with the data of Figure 2 , obtained with the anti-procaspase-8 antibody, these results suggest that, in p63 knockout (KO) mice a significant amount of caspase-8 is cleaved, whereas the vast staining of procaspase-8 in the DNp63a-tg mice is not paralleled by a concomitant increase in active, cleaved caspase-8, as in the wt mice. We also performed TUNEL assays on the wt, KO and transgenic mice, to analyse the apoptotic state of mouse skin. As expected, in wt mice apoptotic events occur rarely, and only in cells of the subcorneum layer ( Figure 5b) ; KO mice display copious apoptotic epithelial cells. Finally, DNp63-Tg show only some TUNEL-positive cells, a clear reduction with respect to KO animals. In conclusion, p63 elimination led to lower levels of caspase-8 expression, but higher apoptosis, and re-expression of DNp63a restores high levels of caspase-8, but lowers apoptosis. The same results were obtained by evaluating procaspase-8 and cleaved caspase-8 levels in human interfollicular epidermis (Supplementary Figure 3) . Taken together, these results indicate that DNp63 regulate genes controlling not only caspase-8 transcription, but also its activation. Figure 6b and c: FLIPl and FLIPs do not show significant changes in mRNA, or protein levels. On the other hand, the mRNA levels of FLIPr are decreased after p63 interference, and conversely, increased by DNp63a overexpression, matching the protein levels tested by western blots. These findings indicate that p63 is able to positively regulate FLIP expression at the transcriptional level.
c-FLIP is downregulated upon UVB irradiation. We analysed the effect of UVB irradiation on the expression of FLIP. As shown in Figure 7a , UVB irradiation leads to a strong decrease of all FLIP variants; p63 levels are also decreased, in these conditions, as reported earlier. 27, 28 As a control for this analysis, we verified the levels of Jun-B, whose expression levels are known to be increased, 29 and (Figure 7a ). We overexpressed DNp63a in NHEK, exposed them 24 h after transfection to UVB irradiation, and analysed FLIP by semiquantitative RT-PCR and western blots: we observed increased FLIPr levels, but not of the other two splicing isoforms, FLIPs and FLIPl. As shown in Figure 7b , p63 overexpression significantly prevented FLIPl downregulation after UVB irradiation, both at the mRNA and protein levels. The mRNAs of all FLIP isoforms dramatically drop after UV treatment, as expected from the decrease of p63. Upon overexpression of p63, mRNA levels increase robustly in the absence of UV, particularly of the antiapoptotic s and r isoforms. These isoforms are also increased upon UV irradiation, when compared with cells with normal levels of p63. The recovery is not complete, but the increase is actually more robust than in non UV-irradiated cells (compare lanes 1-3 and 2-4). In summary, all these results are in full agreement with a positive role of p63 in c-FLIP regulation.
FLIP expression in p63 KO mice. We investigated FLIP expression in the skin of the p63 mice models used above. As shown in Figure 8 , FLIP shows a diffuse nuclear and cytoplasmic staining, in cells normally expressing p63, and a cytoplasmic staining in cells which do not express p63 ( Figure 8 , upper panels, white arrow). In p63 KO mice, we analysed FLIP and the cK14 marker: weaker staining is detected in K14 þ cells, compared to wt mice. Furthermore, KO mice show a cytoplasmic staining of FLIP. These in vivo data further substantiate the notion that FLIP is regulated by p63 in mouse skin. Discussion p63 and apoptosis. The role of p63 in apoptosis pathways is debated. Gressner et al. 9 described the role of TAp63a in activating apoptosis through death receptors and mitochondria by activating transcription of p53 targets. 14 DNp63 is believed to compete for, or form a transactivation incompetent heterocomplex with, p53 and TAp63. 8 Zebrafish studies confirmed the antagonistic roles of DNp63 and p53. 10 Thus, one could tentatively conclude that the antiapoptotic role of DNp63 reflects its negative impact on p53 functions. However, DNp63a RNAi led to DNA damage-induced apoptosis in cells carrying p53 mutant alleles, which have visibly lost proapoptotic behaviours, suggesting that additional antiapoptotic functions of DNp63a are crucially required. 7 This hypothesis is in agreement with the reported sensitivity of p53-mutated HaCat cells to UVB irradiationmediated apoptosis. 30 In Figure 1 , TA isoforms are more potent in Luciferase assays, especially the b and g isoforms, but we think that this should not be taken as an indication that p63 targets in apoptotic pathways S Borrelli et al procaspase-8 is more of a target of TA than DN isoforms: in fact, we have noticed this behaviour routinely, even in promoters characterized as bona fide targets of DNp63a. 13, 14 It is likely that this effect is due to the properties of the transient assays, which are presumably not including chromatin constraints.
In theory, p73 and p53 could also regulate the caspase-8-FLIP pathway, but several arguments specifically point toward p63 in keratinocytes under physiological conditions. (i) There is no genetic evidence linking p73 or p53 to significant developmental networks in keratinocytes, as KO mice have no overt skin alterations. (ii) Although the levels of p63 in human skin and keratinocytes are very robust, those of p73 -and p53 -are extremely low, if ever appreciable. (iii) We performed ChIPs in human keratinocytes with p73 antibodies and failed to obtain any results on any targets of p63 (S.B., not shown). Thus the role of p73 in the caspase-8-FLIP pathway should be explored in cellular systems where robust p73 levels are physiologically scored and in pathologic conditions, such as in tumours, where increased p73 levels -and mutated p53 -might well change the balance.
Transgenic mice overexpressing DNp63a display an impaired ability of epidermal keratinocytes to undergo apoptosis in response to UVB irradiation 27 and DNp63a expression is reduced in response to UVB, suggesting that p63 downregulation is necessary to allow apoptotic pathways. We find that overexpression of DNp63 protects primary human keratinocytes from apoptosis, whereas p63 inactivation dramatically enhances this phenomenon. We also confirm the decrease, but not the abolition of p63 expression upon UV irradiation. We note that this is specifically observed in UVB, as compared with UVC irradiation. Similarly, in mouse keratinocytes, p63 protects from apoptosis, as assessed by assays of caspase-3 cleavage. 28 Mechanistically, the DNp63a ability to inhibit the proapoptotic function of TAp63 relies on the transcription inhibitory -TI -domain. It was demonstrated that p63 is itself a caspase target: cleavage of TAp63a by activated caspases lead to the loss of the TI domain, enhancing its transcriptional -and proapoptotic -activities. 31 In contrast, cleavage of DNp63a does not affect its transactivation, but remove its inhibitory effect on TAp63 isoforms. All these considerations lead to our surprise in finding a proapoptotic gene, caspase-8, among the targets of DNp63a, in unbiased RNAi profiling experiments.
p63
and caspase-8. Although caspase-8 posttranscriptional regulation has been studied in great detail, less is known about its transcriptional activation, which varies ChIP analysis, as well as studies in p63 KO and DNp63a-tg mice confirmed direct regulation of caspase-8, in vivo. Note that the overlap between p63 and procaspase 8 is not absolute in transgenics, as there are cells that are negative for the latter: therefore there are additional signals that limit procaspase-8 expression in selected cellular populations. The mRNA expression in NHEK fits with the levels of procaspase-8 protein, clearly detectable by IFs staining, both in human and mouse skin. Following UVB irradiation, both procaspase-8 and p63 transcription decreases, whereas proteolytic activation of caspase-8 activates apoptosis through inactivation of FLIP, the key negative regulator of procaspase-8.
p63 and FLIP. Caspase-8 activation is inhibited at the DISC by different FLIP splice variants at two different cleavage steps. Products released from the DISC upon receptor triggering depend on the ratios of procaspase-8 and FLIP at the DISC. Low levels of FLIP proteins allow processing of procaspase-8, giving rise to the active heterotetramer. High levels of FLIP L allow procaspase-8 recruitment at the DISC, but cleavage is blocked after the generation of the p43 product of caspase-8 and its role as an antiapoptotic molecule is still debated. 22, 23 High levels of FLIPs and FLIPr lead to the recruitment at the DISC, but the cleavage is plugged and ineffective: hence, these isoforms are essentially antiapoptotic. 33 Our results suggest that p63 supports specifically FLIPr expression in non apoptotic conditions: following UVB exposure, FLIPr and FLIPs decrease, whereas FLIPl levels remain unaffected: the balance shifts in favour of the latter, resulting in the p41/ p43 kDa products (Figure 7) . FLIP can be regulated at multiple levels and transcription is modulated by NF-kB, c-MYC, AR and AP1 family members, 34 whereas p53 can downregulate protein levels through the ubiquitin-proteasome system, in a transcription-independent manner. 35 Here, we describe two important findings: (i) direct (ii) modulation of the FLIP isoforms, which differentially impact on apoptosis. Transcription factors often control not only the overall rate of transcription initiation, but also the specific mRNA isoform produced (Reviewed by Fukazawa et al. 35 ). Indeed, DNp63a was earlier reported to modulate splicing events of target genes; 36 the ability of p53 to regulate FLIP-protein levels 35 suggests antagonistic roles. There are additional levels of common p63-FLIP regulation: one is represented by the the ubiquitin E3 ligase Itch, which specifically ubiquitylates FLIP and DNp63, inducing its proteosomal degradation. 37 Another level is represented by transcription factors known to regulate FLIP, which are also p63 targets: c-jun and Jun-B; 14 the former, in combination with Fos, represses c-FLIP expression. 34 NF-kB activates the FLIP promoter, [38] [39] and its regulator IkB kinase a is induced by DNp63a. 40 The FLIP promoter is therefore at the centre of converging and interconnected survival pathways -p63 and NF-kB -as well as proapoptotic signals (c-jun). Hence, caspase-8 and FLIP are linked by a common fate, regulated at the transcriptional, post-transcriptional and post-translational levels.
Apoptosis in the skin. Two very important, completely unrelated processes of programmed cell death occur in the skin: apoptosis and cornification ( Figure 9 ). Apoptosis is necessary for balancing keratinocyte responses to external toxic insults, such as UV, thus producing 'sun burn' cells; cornification is responsible for the formation of the stratum corneum. This layer is fundamental for the mechanical, impermeable and elastic barrier of our body, requiring a specific and sophisticated mechanism of differentiation. 26 In gross terms, apoptosis occurs in the lower layers of the epidermis, and seems to be repressed in the middle/upper layers, to allow differentiation, a process requiring the expression of toxic proteins -loricrin, involucrin, small proline-rich proteins -which would otherwise trigger apoptosis. Sun burn cells are typical of the basal layer, where the cornification genetic programme is inactive. In normal human epidermis, nine caspase genes are expressed in the lower layers -type-1, -2, -3, -4, -6, -7, -8, -9 and -10 -as part of the protective mechanism dealing with exposure to UV irradiation or DNA-damaging agents. In addition, Caspase-14 is implicated in terminal keratinocyte differentiation and cornification. 41 In summary, we employed several approaches to detail how DNp63a acts to sustain a proapoptotic pathway necessary to cope with an excess of dangerous environmental signals -UVB -while ensuring the efficient and fine-tuned expression of a dominant antiapoptotic gene. This is compatible with the hypothesis that, in actively proliferating cells of the lower epithelial layers, apoptosis is important for the response to toxic agents, placing p63 as a pivotal regulator of this balance.
Materials and Methods
Cells and culture conditions. HaCat were grown in DMEM in the presence of 10% fetal calf serum. First passage primary human keratinocytes -NHEK -were derived from the breast of healthy individuals and grown on a feeder-layer of lethally irradiated 3T3 cells in DMEM F12 added with insulin (5 mg/ml), EGF-R (10 ng/ml) hydrocortisone (0.4 mg/ml), T3 (2 nM), cholera toxin (0.1 nM) and transferrin (5 mg/ml).
RT-PCR and transfections. HaCat cells were transiently transfected using Oligofectamine (Gibco-BRL, USA) for 3 hours with 150 ng/cm 2 of human p63 siRNA oligonucleotide, which targets the central DNA-binding domain of p63.
14 After overnight incubation, transfection was repeated for 3 additional hours. 2.5 Â 10 5 first passage NHEK were transfected with Nucleofector (Amaxa, Germany) using siRNA oligonucleotide at 0.5 nM. An off-target siRNA oligos mixture (5 0 -AUGAACGUGAAUUGCUCAA-3 0 , 5 0 -UAAGGCUAUGAAGAGAUAC-3 0 , 5 0 -AU GUAUUGGCCUGUAUUAG-3 0 , 5 0 -UAGCGACUAAACACAUCAA-3 0 ; Dharmacon D-00181001) was used as control. NHEK cells silenced with a shRNA plasmid targeting all p63 isoforms (MISSION shRNA plasmid, Sigma) using Lipofectamine (Gibco-BRL); 5 mg of shRNA plasmid and a scramble sh control were used. RNA was extracted with RNA-Easy kit (Quiagen), 48 h after siRNA transfections and 96 h after shRNA transfections. For cDNA synthesis, 4 mg of RNA were retrotranscribed with M-MLV-RT kit (Invitrogen, USA). Semiquantitative PCR analysis was performed with primers listed in Supplementary Figure 4 . Keratinocytes were irradiated 96 h after transfections. They were exposed to 250 and 400 J/m 2 UVB from lamps emitting light of wavelength from 275 to 400 nm, peaking at 315 nm. For transactivation experiments, 1 Â 10 5 NHEK cells were transfected with Lipofectamine (Gibco-BRL) using 1.2 mg of reporter plasmids, 200 ng of p63 different splicing isoforms, and a carrier for a total DNA of 2 mg. Four independent transfections in duplicate were performed. 
